Status:
COMPLETED
Long Term Follow up of Water Vapor Thermal Therapy (Rezum) for Benign Prostatic Hyperplasia (BPH)
Lead Sponsor:
Helwan University
Conditions:
Benign Prostatic Hyperplasia
Lower Urinary Track Symptoms
Eligibility:
MALE
40-80 years
Phase:
NA
Brief Summary
This study aims to assess the effectiveness and morbidity of water vapor thermal therapy (Rezūm therapy) for benign prostatic hyperplasia (BPH). Data will be collected and analyzed from patients treat...
Detailed Description
The investigators will conduct a retrospective study evaluating patients treated with water vapor thermal therapy (Rezūm therapy) for BPH and followed up for4 years. The primary objectives are to asse...
Eligibility Criteria
Inclusion
- patients underwent rezum procedure for benign prostatic hyperplasia from 2 to 4 years
Exclusion
- previous prostatic intervention
- concurrent urological morbidity like urethral stricture
- neurological disease like parkinson's disease
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2025
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT05982444
Start Date
March 1 2021
End Date
May 1 2025
Last Update
June 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine Helwan University
Helwan, Cairo Governorate, Egypt, 11795